SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 170 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2017. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $79,000 | -52.1% | 43,674 | -40.8% | 0.00% | -50.0% |
| Q4 2017 | $165,000 | -29.5% | 73,774 | -8.6% | 0.01% | -25.0% |
| Q3 2017 | $234,000 | -26.2% | 80,674 | +13.3% | 0.01% | -33.3% |
| Q2 2017 | $317,000 | -60.1% | 71,174 | -58.3% | 0.01% | -60.0% |
| Q1 2017 | $795,000 | -68.5% | 170,505 | -58.8% | 0.03% | -68.4% |
| Q4 2016 | $2,521,000 | +3261.3% | 413,882 | +1432.9% | 0.10% | +4650.0% |
| Q1 2016 | $75,000 | -76.7% | 27,000 | -55.6% | 0.00% | -77.8% |
| Q3 2015 | $322,000 | +122.1% | 60,750 | +247.1% | 0.01% | +125.0% |
| Q2 2015 | $145,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
| Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
| Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
| Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
| Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
| KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
| Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |